Greenspace Health Secures Series B Investment
Greenspace Health, a Toronto, Canada-based provider of SaaS measurement-based care platform, has secured a Series B growth equity investment.
The round was led by ABS Capital Partners, which provides growth equity to B2B software and tech-enabled services businesses with strong data and technology foundations. With over 30 years of experience, ABS Capital has invested more than $2.5 billion across 130 companies. ABS Capital partners with management teams to accelerate growth through operational support, market research, and business strategies, focusing on scaling businesses into industry leaders.
The investment will support Greenspace’s continued growth, further developing its MBC technology to enhance provider efficiency, clinical outcomes, and data-driven insights across the behavioral healthcare industry.
Greenspace Health offers SaaS measurement-based care solutions to improve mental health outcomes by integrating data-driven care across clinical, organizational, and community settings. Their platform enables mental health providers to use evidence-based measurements, such as patient-reported outcome measures (PROMs), to enhance treatment effectiveness, increase engagement, and support better decision-making. Used by over 500 organizations, including clinics, hospitals, insurers, and health systems, Greenspace Health is headquartered in Toronto, Canada, with operations in Washington, D.C.
Funding Details
Company: Greenspace Mental Health Ltd.
Raised: Undisclosed
Round: Series B
Funding Date: March 2025
Lead Investor: ABS Capital Partners
Additional Investors:
Company Website: https://greenspacehealth.com/
Software Category: SaaS Measurement-Based Care